首页 正文

Effect of the IDH1 inhibitor combined with hypomethylating agents on acute myeloid leukemia

{{output}}
Objective: Mutations in the gene encoding isocitrate dehydrogenase 1 (IDH1) occur in approximately 6-10% of acute myeloid leukemia (AML) patients. Ivosidenib (IVO) is a small-molecule inhibitor of mutant IDH1. This study delves i... ...